-
Guggenheim Reaffirms "Buy" Rating for Century Therapeutics (NASDAQ:IPSC)
来源: Buzz FX / 22 1月 2025 10:26:18 America/Chicago
Guggenheim Reaffirms "Buy" Rating for Century Therapeutics (NASDAQ:IPSC) Written by MarketBeat January 22, 2025 Share Link copied to clipboard. Century Therapeutics ( NASDAQ:IPSC - Get Free Report ) 's stock had its "buy" rating restated by
Read more...